S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Join Morningstar today. It's Free.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|Faruqi & Faruqi, LLP is Investigating United Therapeutics Corporation on Behalf of its Shareholders - UTHR (2014/1/9)|
|Japan's Ministry of Health, Labour and Welfare Grants Approval for United Therapeutics' Remodulin (2014/3/26)|
|United Therapeutics Receives Subpoena From Office of Inspector General (2013/12/9)|
|United Therapeutics Corporation Reports Third Quarter 2013 Financial Results (2013/10/29)|
|United Therapeutics Corporation Reports 2013 Fourth Quarter And Annual Financial Results (2014/2/25)|
|United Therapeutics Announces FDA Acceptance of Second Resubmission of Oral Treprostinil NDA (2013/9/11)|
|United Therapeutics Corporation to Announce Third Quarter 2013 Financial Results Before Market Open on Tuesday, October 29, 2013 (2013/10/22)|
|United Therapeutics Corporation To Announce Fourth Quarter And Annual 2013 Financial Results Before Market Open On Tuesday, February 25, 2014 (2014/2/18)|
|FDA Approves Orenitram™ (treprostinil) Extended-Release Tablets for the Treatment of Pulmonary Arterial Hypertension (2013/12/20)|
|Pluristem Issues Letter to Shareholders (2014/1/30)|
Click above to view more mutual fund data and stats for uthr - United Therapeutics Corporation.